Signaling through Toll-like receptor 3 and Dectin-1 potentiates the capability of human monocyte-derived dendritic cells to promote T-helper 1 and T-helper 17 immune responses

Cytotherapy

Volumn 14, Issue 5, 2012, Pages 598-607

  Dragicevic, Ana ^a   Dzopalic, Tanja ^a,b   Vasilijic, Sasa ^a   Vucevic, Dragana ^a   Tomic, Sergej ^a   Bozic, Biljana ^a,c   Colic, Miodrag ^b,d  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d Serbia   (Serbia)

Author keywords

Dectin 1 receptor; Human monocyte derived dendritic cells; T helper immune response; Toll like receptor 3

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CURDLAN; DECTIN 1; GAMMA INTERFERON; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; TOLL LIKE RECEPTOR 3;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MIXED LYMPHOCYTE REACTION; MONOCYTE; MONOCYTE DERIVED DENDRITIC CELL; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; UPREGULATION;

EID: 84859745341     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2012.667873     Document Type: Article

References (41)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-52.
2. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol. 2007;7: 179-90.
3. Gilboa E. DC-based cancer vaccines. J Clin Invest. 2007;117: 1195-203.
4. Sallusto F, Lanzavecchia A. Effi cient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179:1109-18.
5. De Vries IJ, Krooshoop DJ, Scharenborg NM, Lesterhuis WJ, Diepstra JH, Van Muijen GN, et al. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 2003;63:12-17.
6. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik, L, Schmitt E, et al. Pro-infl ammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol. 1997;27:3135-42.
7. Pedersen AE, Buus S, Claesson MH. Treatment of transplanted CT26 tumour with dendritic cell vaccine in combination with blockade of vascular endothelial growth factor receptor 2 and CTLA-4. Cancer Lett. 2006;235:229-38.
8. Padovan E, Landmann RM, De Libero G. How pattern recognition receptor triggering infl uences T cell responses: a new look into the system. Trends Immunol. 2007;28:308-14.
9. Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med. 1999;189:821-9.
10. Dennehy KM, Brown GD. The role of the beta-glucan receptor Dectin-1 in control of fungal infection. J Leukoc Biol. 2007;82: 253-8.
11. LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol. 2007;8:630-8.
12. Agrawal S, Gupta S, Agrawal A. Human dendritic cells activated via Dectin-1 are effi cient at priming Th17, cytotoxic CD8 T and B cell responses. PLoS One. 2010;5:e13418.
13. Muzio M, Bosisio D, Polentarutti N, D 'A mico G, Stoppacciaro A, Mancinelli R, et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol. 2000;164: 5998-6004.
14. Verdijk RM, Mutis T, Esendam B, Kamp J, Melief CJ, Brand A, et al. Polyriboinosinic polyribocytidylic acid (Poly (I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol. 1999;163:57-61.
15. Rouas R, Lewalle P, El Ouriaghli F, Nowak B, Duvillier H, Martiat P. Poly (I:C) used for human dendritic cell maturation preserves their ability to secondarily secrete bioactive IL-12. Int Immunol. 2004;16:767-73.
16. Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 2000;14:1693-711.
17. Ariizumi K, Shen GL, Shikano S, Xu S, Ritter R 3rd, Kumamoto T, et al. Identifi cation of a novel, dendritic cellassociated molecule, Dectin-1, by subtractive cDNA cloning. J Biol Chem. 2000;275:20157-67.
18. Taylor PR, Brown GD, Reid DM, Willment JA, Martinez- Pomares L, Gordon S, et al. The beta-glucan receptor, Dectin-1, is predominantly expressed on the surface of cells of the monocyte/ macrophage and neutrophil lineages. J Immunol. 2002;169: 3876-82.
19. Skrzypek F, Cenci E, Pietrella D, Rachini A, Bistoni F, Vecchiarelli A. Dectin-1 is required for human dendritic cells to initiate immune response to Candida albicans through Syk activation. Microbes Infect. 2009;11:661-70.
20. Higashi T, Hashimoto K, Takagi R, Mizuno Y, Okazaki Y, Tanaka Y, et al. Curdlan induces DC-mediated Th17 polarization via Jagged1 activation in human dendritic cells. Allergol Int. 2010;59:161-6.
21. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Wevers B, Bruijns SCM, et al. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk Nat Immunol. 2009;10: 203-13.
22. Stopinaek S, Ihan A, Wraber B, Ter e lj M, Salobir B, Rylander R, et al. Fungal cell wall agents suppress the innate infl ammatory cytokine responses of human peripheral blood mononuclear cells challenged with lipopolysaccharide in vitro. Int Immunopharmacol. 2011;11:939-47.
23. Snijders A, Kalinski P, Hilkens CMU, Kapsenberg ML. High-level IL-12 production by human dendritic cells requires two signals. Int Immunol. 1998;10:1593-7.
24. Boniface K, Blumenschein WM, Brovont-Porth K, McGeachy MJ, Basham B, Desai B, et al. Human Th17 cells comprise heterogeneous subsets including IFN- producing cells with distinct properties from the Th1 lineage. J Immunol. 2010;185: 679-87.
25. Dennehy KM, Willment JA, Williams DL, Brown GD. Reciprocal regulation of IL-23 and IL-12 following coactivation of Dectin-1 and TLR signaling pathways. Eur J Immunol. 2009;39:1379-86.
26. Gerosa F, Baldani-Guerra B, Lyakh LA, Batoni G, Esin S, Winkler-Pickett RT, et al. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J Exp Med. 2008;205:1447-61.
27. Hsu YMS, Zhang Y, You Y, Wang D, Li H, Duramad O, et a l. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat Immunol. 2007;8: 198-205.
28. Gross O, Gewies A, Finger K, Schafer M, Sparwasser T, Peschel C, et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature. 2006;442:651-6.
29. Colonna M. All roads lead to CARD9. Nat Immunol. 2007; 8:554-5.
30. Weck MM, Appel S, Werth D, Sinzger C, Bringmann A, Gr nebach F, et al. hDectin-1 is involved in uptake and crosspresentation of cellular antigens. Blood. 2008;111:4264-72.
31. + T cells. Immunity. 2002;16:779-90.
32. + T cells partially through STAT3- dependent mechanism. J Immunol. 2006;177:5377-85.
33. Jankovic D, Trinchieri G. IL-10 or not IL-10: that is the question. Nat Immunol. 2007;8:1281-3.
34. Saraiva M, Christensen JR, Veldhoen M, Murphy TL, Murphy KM, O ' Garra A. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity. 2009; 31:209-19.
35. Ikeda H, Old LJ, Schreiber RD. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 2002;13:95-109.
36. Nishimura T, Nakui M, Sato M, Iwakabe K, Kitamura H, Sekimoto M, et al. The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother Pharmacol. 2000;46(Suppl):S52-61.
37. + IL-17- producing T cells in ovarian cancer. Proc Natl Acad Sci USA. 2008;105:15505-10.
38. Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, et al. Phenotype, distribution, generation functional and clinical relevance of Th17 cells in the human tumor environments. Blood. 2009;6:1141-9.
39. Alshaker HA, Matalka KZ. IFN-γ?, IL-17 and TGF-β involvement in shaping the tumor microenvironment: the signifi- cance of modulating such cytokines in treating malignant solid tumors. Cancer Cell Int. 2011;11:33.
40. Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, Kaiser A, et al. Tumor-specifi c Th17-polarized cells eradicate large established melanoma. Blood. 2008;112:362-73.
41. Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, Lu S, et al. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity. 2009;31:787-98.